Jan 15, 2012 · In observational studies of men with prostate cancer, men on endocrine treatment (ET) have had an increased risk of ischemic heart disease (IHD) and stroke.
In observational studies of men with prostate cancer, men on endocrine treatment (ET) have had an increased risk of ischemic heart disease (IHD) and stroke.
People also ask
Can hormone therapy for prostate cancer cause heart problems?
What is the link between prostate cancer and heart disease?
What is the endocrine treatment for prostate cancer?
What are the cardiovascular risks of androgen deprivation therapy for prostate cancer?
Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and relative CVD risk ...
Ischemic Heart Disease and Stroke Before and During Endocrine Treatment for Prostate Cancer in PCBaSe Sweden. Int J Cancer. 2012 Jan 15;130(2):478-87. Akre ...
Jun 25, 2020 · In this study using national health insurance data, we investigated the risk of ischemic heart disease (IHD) and stroke among prostate cancer (PC) survivors
May 4, 2012 · , et al. Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. ,. Int J Cancer. ,. 2012.
All men with prostate cancer were at higher risk of thromboembolic diseases, with the highest risk for those on endocrine therapy. Our results indicate that ...
Missing: Ischemic | Show results with:Ischemic
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden. Int J Cancer. 2012; 130:478-487. Crossref · Scopus ...
We assessed the frequency of multiple events (fractures, stroke, heart disease [HD], and thromboembolic disease [TED]) following PCa diagnosis. Design, setting, ...
PURPOSE Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and ...